1. Home
  2. NXRT vs YDES Comparison

NXRT vs YDES Comparison

Compare NXRT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Residential Trust Inc.

NXRT

NexPoint Residential Trust Inc.

HOLD

Current Price

$26.51

Market Cap

617.2M

Sector

Real Estate

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.21

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NXRT
YDES
Founded
2014
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
617.2M
543.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
NXRT
YDES
Price
$26.51
$5.21
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$31.00
N/A
AVG Volume (30 Days)
204.5K
22.4K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
8.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$251,281,000.00
N/A
Revenue This Year
$3.09
N/A
Revenue Next Year
$3.02
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.79
$5.40
52 Week High
$38.93
$25.00

Technical Indicators

Market Signals
Indicator
NXRT
YDES
Relative Strength Index (RSI) 57.40 32.03
Support Level $23.82 N/A
Resistance Level $32.12 $9.11
Average True Range (ATR) 0.62 0.70
MACD 0.34 -0.12
Stochastic Oscillator 99.82 2.66

Price Performance

Historical Comparison
NXRT
YDES

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: